Pharmaceutical Companies:

Espicom
Market Briefing  September 2005

Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 40 Company Intelligence Reports are currently available.

288 pages.

GlaxoSmithKline was founded on 27th December 2000 via the merger of the UK's two biggest pharmaceutical companies, Glaxo Wellcome (GW) and SmithKline Beecham (SB). According to GSK, it is now the world's second biggest pharmaceutical company, just behind Pfizer.

GSK's Pharmaceutical division concentrates on eight major therapeutic areas: oncology and emesis, central nervous system disorders (depression and migraine), respiratory disorders, bacterial infections, viral infections (HIV and herpes), metabolic and gastrointestinal disorders, vaccines and cardiovascular disease. It is also active in the fields of arthritis and dermatologicals as well as vaccines and pharmaccines.

Cancer Snapshot Contents
1. Agreements Table
2. Product Portfolio Table
3. R&D Pipeline Table
4. Overview
5. Agreements
6. Product Portfolio
7. R&D Projects

The full Company Intelligence Report report provides a comprehensive review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis.

For full details, please email jenniferc@cmsinfo.com

Order Form

For more information about us, visit CMSinfo.